| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |